Clinical Trials Program

Neurology

The Neurology Clinical Trials program, in collaboration with esteemed sponsors, is dedicated to advancing care for patients with ischemic and hemorrhagic strokes through cutting-edge research with three active studies—ENRICH-AF, LAAOS-4, and Librexia-STROKE. These trials are sponsored by Hamilton Health Sciences Corporation via the Population Health Research Institute (PHRI) (ENRICH-AF and LAAOS-4), and Janssen Research & Development, LLC (Librexia-STROKE). This partnership aims to revolutionize stroke treatment and improve patient outcomes. 

Our Team

Dr. Danielle de Sa Boasquevisque, Physician Lead

Dr. Alicia Mattia, Neurology Lead

Dr. Donald Chew, Neurologist

Leanne Kent, Stroke Program Manager

Charmaine Martin-Gaspar, Nurse Practitioner

Joanne Gorman, Research Co-ordinator

Active Trials

ENRICH-AF 

Edoxaban for IntraCranial Hemorrhage Survivors with Atrial Fibrillation

Learn more 

LIBREXIA-STROKE

A study of Milvexian in participants after an acute ischemic stroke or high-risk transient ischemic attack.

Learn more

LAOOS-4

The Fourth Left Atrial Appendage Occlusion Study

Learn more